AI Article Synopsis

  • This study investigates the genetic connections between oxylipins (inflammatory markers from omega-3 and -6 fatty acids) and their association with inflammatory diseases through a genome-wide association study (GWAS).
  • Researchers analyzed plasma oxylipins from 316 participants in a diabetes study, using DNA genotyping and principal components analysis to categorize oxylipin profiles into two main groups related to different fatty acids.
  • Findings identified significant genetic loci associated with specific oxylipins related to linoleic acid (LA) and arachidonic acid (ARA), highlighting their roles in inflammation and potential targets for future therapies.

Article Abstract

Background: Oxylipins are inflammatory biomarkers derived from omega-3 and-6 fatty acids implicated in inflammatory diseases but have not been studied in a genome-wide association study (GWAS). The aim of this study was to identify genetic loci associated with oxylipins and oxylipin profiles to identify biologic pathways and therapeutic targets for oxylipins.

Methods: We conducted a GWAS of plasma oxylipins in 316 participants in the Diabetes Autoimmunity Study in the Young (DAISY). DNA samples were genotyped using the TEDDY-T1D Exome array, and additional variants were imputed using the Trans-Omics for Precision Medicine (TOPMed) multi-ancestry reference panel. Principal components analysis of 36 plasma oxylipins was used to capture oxylipin profiles. PC1 represented linoleic acid (LA)- and alpha-linolenic acid (ALA)-related oxylipins, and PC2 represented arachidonic acid (ARA)-related oxylipins. Oxylipin PC1, PC2, and the top five loading oxylipins from each PC were used as outcomes in the GWAS (genome-wide significance:  < 5×10).

Results: The SNP rs143070873 was associated with (p < 5×10) the LA-related oxylipin 9-HODE, and rs6444933 (downstream of ) was associated with the LA-related oxylipin 13 S-HODE. A locus between and , rs10118380 and an intronic variant in were associated with the ARA-related oxylipin 11-HETE. These loci are involved in inflammatory signaling cascades and interact with , an initial step to oxylipin biosynthesis.

Conclusion: Genetic loci involved in inflammation and oxylipin metabolism are associated with oxylipin levels.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086335PMC
http://dx.doi.org/10.3389/fnut.2023.1040993DOI Listing

Publication Analysis

Top Keywords

oxylipins oxylipin
12
oxylipin profiles
12
oxylipins
8
plasma oxylipins
8
genome-wide analysis
4
analysis oxylipins
4
oxylipin
4
profiles pediatric
4
pediatric population
4
population background
4

Similar Publications

Background: Polyunsaturated fatty acids are metabolized by cytochrome P450 (CYP450) into anti‐inflammatory, pro‐resolving epoxides, which are rapidly converted to inactive and cytotoxic diols by soluble epoxide hydrolase (sEH). Increased CYP450‐sEH metabolites are associated with worse cognition in type 2 diabetes mellitus (T2DM), and greater white matter hyperintensities (WMH) in patients with stroke. We examined whether the relationship between linoleic acid (LA)‐derived CYP450‐sEH metabolites (oxylipins) and small vessel disease (SVD) markers differ across diabetes status.

View Article and Find Full Text PDF

Background: Oxylipins are oxygenated fatty acid (FA) metabolites that are important mediators of inflammation. Neuroinflammation is a hallmark of Alzheimer’s disease (AD), and brains of AD patients contain more pro‐inflammatory and less anti‐inflammatory oxylipins compared to healthy controls. Free fatty acid receptor 4 (Ffar4) is a G‐protein coupled receptor for medium and long‐chain FAs, including, but not limited to, omega‐3‐polyunsaturated FAs.

View Article and Find Full Text PDF

Contribution of individual phospholipase A enzymes to the cleavage of oxidized phospholipids in human blood plasma.

J Lipid Res

January 2025

Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Graz, Graz, Austria; Field of Excellence BioHealth - University of Graz, Graz, Austria. Electronic address:

Phospholipids containing oxidized esterified PUFA residues (OxPLs) are increasingly recognized for multiple biological activities and causative involvement in disease pathogenesis. Pharmacokinetics of these compounds in blood plasma is essentially not studied. Human plasma contains both genuine phospholipases A (PAF-AH (also called Lp-PLA) and sPLA) and multifunctional enzymes capable of removing sn-2 residues in native and oxidized PLs (LCAT, PRDX6).

View Article and Find Full Text PDF

Pharmacological reduction of lipid hydroperoxides as a potential modulator of sarcopenia.

J Physiol

January 2025

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

We previously reported that elevated expression of phospholipid hydroperoxide glutathione peroxidase 4, an enzyme that regulates membrane lipid hydroperoxides, can mitigate sarcopenia in mice. However, it is still unknown whether a pharmacological intervention designed to modulate lipid hydroperoxides might be an effective strategy to reduce sarcopenia in aged mice. Here we asked whether a newly developed compound, CMD-35647 (CMD), can reduce muscle atrophy induced by sciatic nerve transection.

View Article and Find Full Text PDF

Plants defend against chewing herbivores by up-regulating jasmonic acid (JA) signaling, which activates downstream signaling cascades and produces numerous secondary metabolites that act as defense molecules against the herbivores. Although secondary metabolism always remains a focus of research, primary metabolism is also reported to be realigned upon herbivory. However, JA signaling-mediated modulation of primary metabolites and their metabolic pathways in plants are mostly unexplored.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!